Top Clinical Trials companies in United Kingdom by Net Cash Used For Investing Activities
United Kingdom
# |
Name |
Net Cash Used For Investing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 20.90 M
|
Dec. 31, 2023 | USD 5.61 | -4.92% |
|
United Kingdom |
|
| 2 |
USD 3.67 M
|
Dec. 31, 2023 | USD 1.04 | 1.96% |
|
United Kingdom |
|
| 3 |
USD 240.17 K
|
Dec. 31, 2023 | USD 0.04 | -14.59% |
|
United Kingdom |
|
| 4 |
USD 222.35 K
|
April 30, 2024 | USD 0.11 | -4.08% |
|
United Kingdom |
|
| 5 |
USD 173.04 K
|
Dec. 31, 2023 | USD 0.04 | 0.09% |
|
United Kingdom |
|
| 6 |
USD -231.00 K
|
Dec. 31, 2023 | USD 0.05 | -16.59% |
|
United Kingdom |
|
| 7 |
USD -419.00 K
|
Dec. 31, 2023 | USD 3.06 | -8.38% |
|
United Kingdom |
|
| 8 |
USD -2.93 M
|
Dec. 31, 2023 | USD 14.81 | -2.31% |
|
United Kingdom |
|
| 9 |
USD -3.84 M
|
Dec. 31, 2023 | USD 0.49 | 0.09% |
|
United Kingdom |
|
| 10 |
USD -5.41 M
|
Dec. 31, 2023 | USD 0.95 | 0.80% |
|
United Kingdom |
|
| 11 |
USD -5.42 M
|
Dec. 31, 2023 | USD 28.56 | -4.90% |
|
United Kingdom |
|
| 12 |
USD -6.59 M
|
Dec. 31, 2023 | USD 0.21 | 6.16% |
|
United Kingdom |
|
| 13 |
USD -10.99 M
|
Dec. 31, 2023 | USD 2.21 | -3.91% |
|
United Kingdom |
|
| 14 |
USD -11.45 M
|
Dec. 31, 2023 | USD 0.62 | -2.80% |
|
United Kingdom |
|
| 15 |
USD -127.00 M
|
Dec. 31, 2023 | USD 14.84 | -2.75% |
|
United Kingdom |
Frequently Asked Questions
-
Which Clinical Trials company in United Kingdom has the highest Net Cash Used For Investing Activities ?
The Clinical Trials company in United Kingdom with the highest Net Cash Used For Investing Activities is Silence Therapeutics plc (NasdaqGM: SLN) at USD 20.90 M.
-
Which Clinical Trials company in United Kingdom has the lowest Net Cash Used For Investing Activities ?
The Clinical Trials company in United Kingdom with the lowest Net Cash Used For Investing Activities is Centessa Pharmaceuticals plc (NasdaqGS: CNTA) at USD -127.00 M.
-
What are the top 10 Clinical Trials companies in United Kingdom by Net Cash Used For Investing Activities ?
The top 10 Clinical Trials companies in United Kingdom by Net Cash Used For Investing Activities are Silence Therapeutics plc, NuCana plc, ImmuPharma plc, Scancell Holdings plc, GENinCode plc, Verici Dx plc, Mereo BioPharma Group plc, Bicycle Therapeutics plc, Cambridge Cognition Holdings Plc and Barinthus Biotherapeutics plc.
-
What are the bottom 10 Clinical Trials companies in United Kingdom by Net Cash Used For Investing Activities ?
The bottom 10 Clinical Trials companies in United Kingdom by Net Cash Used For Investing Activities are Centessa Pharmaceuticals plc, Avacta Group Plc, Autolus Therapeutics plc, hVIVO plc, Immunocore Holdings plc, Barinthus Biotherapeutics plc, Cambridge Cognition Holdings Plc, Bicycle Therapeutics plc, Mereo BioPharma Group plc and Verici Dx plc.